معرفی
Shawn Gale is a full-time Professor in the Neuroscience program at Brigham Young University's College of Life Sciences, holding a PhD in Psychology from BYU. A licensed psychologist since 1995 and board-certified clinical neuropsychologist since 2000, he maintains active clinical experience across private practice (Salt Lake City), University of Virginia's Department of Physical Medicine & Rehabilitation, and Barrow Neurological Institute in Phoenix.
His educational background includes:
- Postdoctoral Fellowship, LDS Hospital (1995)
- PhD in Psychology, Brigham Young University (1994)
- MS in Experimental Psychology, Brigham Young University (1990)
- BS in Psychology, Brigham Young University (1988)
Dr. Gale's research pioneers the investigation of infectious disease burden as a modifiable risk factor for neurocognitive decline, utilizing BYU's MRI Research Facility for neuroimaging and large-scale epidemiological methods. His work spans traumatic brain injury, epilepsy, and dementia, with recent breakthroughs on pathogens like Toxoplasma gondii, HPV, and Helicobacter pylori impacting cognitive function across the lifespan. This interdisciplinary approach integrates clinical neuropsychology, neuroepidemiology, and environmental health to identify novel dementia prevention strategies.
Analysis of his 15 most recent publications (2023-2025) reveals a dominant research trajectory: infectious agents and environmental pollutants as underexplored determinants of brain health. Key themes include pathogen-specific cognitive impacts (e.g., Toxoplasma gondii altering brain structure), synergistic effects of infection burden with cardiovascular disease, and population-level evidence linking HPV/HIV to neurocognitive deficits—providing critical evidence for infectious disease control in dementia prevention.
Professional recognition includes:
- Licensed Psychologist (1995)
- Board Certified Clinical Neuropsychologist, American Board of Professional Psychology (2000)
As an educator, Dr. Gale trains students in Clinical Neuropsychology and Brain-Behavior relationships through the Neuroscience program. His research team leverages BYU's MRI Research Facility for neuroimaging studies, with ongoing projects examining infection-cognition interactions in aging populations. Future work will expand into longitudinal tracking of infection burden effects on brain volumetrics and white matter integrity, supported by collaborations with national health surveys.
He maintains active leadership in professional societies including the American Academy of Clinical Neuropsychology (2000-present), International Neuropsychological Society (1995-present), and National Academy of Neuropsychology (1995-present).
